| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/16/1999 | WO1999045776A1 Treatment of respiratory disease and otitis media |
| 09/16/1999 | WO1999032082A3 Pharmaceutical compositions |
| 09/16/1999 | WO1999028304A9 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2322848A1 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are effected |
| 09/16/1999 | CA2322839A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2321935A1 Use of alpha-rar antagonists for inhibition of mucin secretion |
| 09/15/1999 | EP0941991A1 2,4-Bis (4-amidino)phenyl furans as anti-pneumocystis carinii agents |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941245A1 Promoter for smooth muscle cell expression |
| 09/15/1999 | EP0941241A1 $i(BORDETELLA) STRAIN EXPRESSING THE FHA HYBRID, LIPOSOMES AND VACCINES |
| 09/15/1999 | EP0941108A1 Wound healing and treatment of fibrosis |
| 09/15/1999 | EP0941099A1 Method of treating bronchitis with uridine triphosphates and related compounds |
| 09/15/1999 | EP0941091A1 Composition, for the treatment of asthma, containing loratadine and a decongestant |
| 09/15/1999 | EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases |
| 09/15/1999 | EP0941083A1 Pharmaceutical compositions containing 3-iodo-1,2-propanediol having mucolytic activity |
| 09/15/1999 | EP0941081A2 New use of creatine |
| 09/15/1999 | EP0941067A2 Stable glassy state powder formulations |
| 09/15/1999 | EP0799188B1 Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0733051B1 Bicyclic heterocycles as neurokinin a antagonists |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228772A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228771A 1,3-diheterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228712A Aqueous-based pharmaceutical composition |
| 09/15/1999 | CN1228706A Hydrogenous medicament |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228333A Yanminling throat sprayer and its preparing technology |
| 09/14/1999 | US5952510 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity |
| 09/14/1999 | US5952001 Preparing pharmaceutical, dermatological or cosmetic preparations for the prevention or treatment of allergic manifestations such as skin allergy, bronchial asthma, or inflammation, or as free radical scavengers |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045009A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 09/10/1999 | WO1999044998A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
| 09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999044606A1 Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma |
| 09/10/1999 | WO1999044597A2 Use of macrolide compounds for the treatment of ards |
| 09/10/1999 | WO1999044592A1 Anti-asthma therapy |
| 09/10/1999 | WO1999027920A3 Use of phospholipids for the manufacture of a medicament for the treatment of asthma |
| 09/10/1999 | WO1998053839A3 Anti-cancer products for treating cystic fibrosis |
| 09/10/1999 | CA2323173A1 Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma |
| 09/10/1999 | CA2322541A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
| 09/09/1999 | DE19809144A1 Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten New asymmetrically substituted carboxylic acid derivatives, their preparation and use as a mixed ET¶LAMBDA¶ / ET¶B¶ receptor antagonists |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0940143A2 Use of PKC-inhibitors for the manufacture of a medicament for the treatment of asthma |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939804A1 NEUTROKINE alpha |
| 09/08/1999 | EP0939758A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/08/1999 | EP0939656A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 09/08/1999 | EP0939637A1 Method of treating sinusitis with uridine triphosphates and related compounds |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0706393B1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 09/08/1999 | CN1228080A Novel immunotherapeutic agents and their use in production of cytokine levels |
| 09/08/1999 | CN1228029A Cross-protective equine herpesvirus preparations and method of making and using same |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948768 Treatment of otitis media by sublingual administration of DNA |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948753 Cyclohexapeptidyl propanolamine compounds |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948430 Water soluble film for oral administration with instant wettability |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | CA2168563C Benzopyrans and pharmaceutical compositions containing them |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2016646C Arylsulphonamides |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0938895A1 New composition to be delivered to the rhinopharyngeal mucose, particularly pernasal |
| 09/01/1999 | EP0938345A1 Aqueous-based pharmaceutical composition |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938331A1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 09/01/1999 | EP0938329A1 Immunogenic tlp composition |
| 09/01/1999 | EP0938322A2 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
| 09/01/1999 | EP0938315A1 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0723455A4 Methods of inhibiting phagocytosis |
| 09/01/1999 | EP0700301B1 Peptides and compounds that bind to elam-1 |
| 09/01/1999 | EP0691842B1 Lidocaine aerosol anaesthetic |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227547A Arylalkanoyl pyridazines |
| 09/01/1999 | CN1227542A N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 09/01/1999 | CN1227491A Method for treating sinusitis with uridine triphosphates and related compounds |
| 09/01/1999 | CN1044906C 3(2H)-pyridazinono derivatives, its preparing method and its composition |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945433 Humans and veterinary science |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | US5945119 A plastic strip having microporous material impregnated with cesium chloride and magnesium sulfate on both side as antiarthritic agent or treatment of other soft tissue injuries; antiinflammatory agents |
| 08/27/1999 | CA2242794A1 2,4-bis[(4-aminidino)phenyl]furans as anti-pneumocystis carini agents |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |